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Abstract
Purpose Despite the positive inﬂuence of spiritual coping
on the acceptance of a cancer diagnosis, higher spirituality
is associated with receipt of more high intensity care at the
end of life. The purpose of our study was to assess the
association between spirituality and type of end-of-life care
received by disadvantaged men with prostate cancer.
Methods We studied low-income, uninsured men in
IMPACT, a state-funded public assistance program, who
had died since its inception in 2001. Of the 60 men who
died, we included the 35 who completed a spirituality
questionnaire at program enrollment. We abstracted socio-
demographic and clinical information as well as treatment
within IMPACT, including zolendroic acid, chemotherapy,
hospice use, and palliative radiation therapy. We measured
spirituality with the Functional Assessment of Chronic
Illness Therapy—Spiritual Well-Being questionnaire
(FACIT-Sp) and compared end-of-life care received
between subjects with low and high FACIT-Sp scores
using chi-squared analyses.
Results A higher proportion of men with high (33%)
versus low (13%) spirituality scores enrolled in hospice,
although our analysis was not adequately powered to dem-
onstrate statistical signiﬁcance. Likewise, we saw a trend
toward increased receipt of palliative radiation among those
with higher spirituality (37% vs. 25%, P = 0.69). The dif-
ferences in end-of-life care received among those with low
andhighspiritualityvariedlittlebytheFACIT-Sppeaceand
faith subscales.
Conclusions End-of-life care was similar between men
with lower and higher spirituality. Men with higher spiri-
tuality trended toward greater hospice use, suggesting that
they redirected the focus of their care from curative to
palliative goals.
Keywords Palliative care  Terminal care  Prostatic
neoplasms  Utilization  Hospice care
Introduction
Religion and spirituality are important coping resources for
many individuals with cancer, and approximately 90% of
individuals dying of cancer cope with their disease under
the aegis of spirituality. Most cancer survivors report
higher levels of spirituality after receiving a cancer diag-
nosis [1–3]. Spiritual insights help those with cancer cope
with their disease, positively evaluate their life, and con-
front possible death [4]. Spirituality uniquely contributes to
the health-related quality of life of men with prostate
cancer and other malignancies by allowing men to enjoy
life, even when facing bothersome symptoms [5–6].
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regarding medical care, specially at the end of life [7–8].
Despite the positive inﬂuence of spiritual coping on the
acceptance of a cancer diagnosis, higher spirituality is
associated with use of less end-of-life planning and more
high intensity care, including mechanical ventilation, car-
diopulmonary resuscitation, and hospitalization at the end
of life [9]. In part due to higher spirituality and a lack of
advanced care planning, minorities and economically dis-
advantaged men utilize advanced directives a lower rate
than their pecunious counterparts [10–11].
High-intensity terminal care improves neither the
quantity nor the quality of life at the end of life, but it does
signiﬁcantly affect costs as death approaches [12–15]. The
purpose of our study was to assess the association between
spirituality and type of end-of-life care received by disad-
vantaged men with prostate cancer and to compare their
care with previous descriptions of care received by more
advantaged men. Based on previous studies showing
increased use of high-intensity care among highly spiritual
men [9], we hypothesized a priori that men with higher
spirituality would utilize hospice resources less frequently
than those with low spirituality, and that those with higher
spirituality would be at least as likely to receive chemo-
therapy, palliative radiation, or zolendroic acid at the end
of life. Due to previously described sociodemographic
variations in hospice use [11, 14, 16], we also posited that
hospice utilization would be lower in our cohort than
among men with greater economic resources.
Methods
Subjects
We studied all 35 low-income, uninsured men in a state-
funded public assistance program who had died since 2001
and had completed a spirituality questionnaire at program
enrollment. IMPACT—Improving Access, Counseling, and
Treatment for Californians with Prostate Cancer (http://
www.california-impact.org)—was developed to provide
access to prostate cancer care for uninsured men with
incomes under 200% of the Federal Poverty Level [17].
Financially eligible men with biopsy-proven prostate can-
cer were assigned a primary cancer care provider, a clinical
care coordinator, and a nurse case manager. They were
also connected with counseling services, educational
materials, transportation assistance, food security, and
housing referrals. They were offered chemotherapy, palli-
ative radiation therapy, zolendroic acid, or hospice care
when deemed appropriate by their clinical providers.
Patients with all tumor grades, disease stages, and history
of previous treatment were included. IMPACT Program
details have been presented previously [17–18].
All demographic and clinical information was obtained
at enrollment and updated during treatment. This included
age, ethnicity, job status, partnership status, region of res-
idence (northern vs. southern California), comorbid con-
ditions, and prior treatments.
Data collection
The University of California, Los Angeles Ofﬁce for Pro-
tection of Research Subjects approved the data collection
protocol, and all procedures were compliant with the
Health Insurance Portability and Accountability Act. Data
were abstracted from an administrative database, which
included entries from case managers, care coordinators,
and nursing providers. Medical chart abstraction from the
IMPACT electronic clinical database and scanned paper
records included review of biopsy reports, physicians’
documentation of initial and follow-up visits, operative
reports, consultation reports, and follow-up encounter
forms. The clinical database and nurses’ records were cross
checked to ascertain ethnicity, income, and other demo-
graphic data. We abstracted patient enrollment in hospice;
date of IMPACT enrollment; length of hospice enrollment
prior to death; tumor grade; clinical disease stage at initial
presentation; initial treatment received at IMPACT; sub-
sequent treatment within IMPACT, including zolendroic
acid, chemotherapy, and palliative radiation therapy;
prostate-speciﬁc antigen (PSA) level prior to initial pros-
tate cancer treatment; documented PSA closest to the time
of death; metastasis at ﬁrst presentation to IMPACT; date
of death; and cause of death. We also noted the number of
prostate cancer-related emergency room visits made while
enrolled in IMPACT.
Spirituality assessment
We measured spirituality and religiosity with the Func-
tional Assessment of Chronic Illness Therapy—Spiritual
Well-Being questionnaire (FACIT-Sp) [19], which is
derived from the Functional Assessment of Cancer Ther-
apy—General survey [20]. The FACIT-Sp contains 12
unique questions, with summary scores ranging from 0 to
48; higher scores indicate greater spirituality. It contains
two subscales: the peace subscale, ranging from 0 to 32,
assesses the existential impact of spirituality, while the
faith subscale, ranging from 0 to 16, measures the strength
and comfort derived from faith and religious beliefs (reli-
giosity). The FACIT-Sp has been validated across several
cultures and literacy levels and has excellent reliability
(Cronbach’s a = 0.87) [6, 21].
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123Statistical analysis
Due to the right-skewed distribution of FACIT-Sp scores,
we empirically dichotomized spirituality and the two sub-
scales into low (FACEIT-Sp\27) versus high (FACIT-
Sp C27), with low spirituality deﬁned as the lowest quar-
tile. Similarly, we deﬁned low (subscale score\18) and
high (subscale score C18) peace and low (subscale
score\8) and high (subscale score C8) faith. Descriptive
statistics for demographic and clinical data, comparing
subjects with low or high spirituality, were derived using
chi-square analyses for categorical variables and the two-
tailed t test for continuous variables. We also compared the
distribution of low and high FACIT-Sp and its two sub-
scales within each type of end-of-life care received. Sta-
tistical analyses were performed with SAS 9.2 software
(SAS Institute, Cary, NC).
Results
Complete demographic and clinical data were available
for all 35 subjects at enrollment. Table 1 shows the demo-
graphic, clinical, and utilization characteristics of our
cohort. Minorities constituted the vast majority of the
study sample, and most were partnered. According to the
D’Amico risk stratiﬁcation [22], all but four (11%) men had
high-risk disease at initial presentation. Androgen depri-
vation therapy was the most common treatment received
within IMPACT. Over one-quarter of men enrolled in
hospice, approximately one-third received palliative radia-
tion therapy, about one-half were treated with zolendroic
acid, and a majority receivedchemotherapy.Our cohort was
divided relatively evenly among those making no prostate
cancer-related emergency room visits (n = 13, 37%), those
making one visit (n = 12, 34%), and those making C2
visits (n = 10, 29%).
Bivariate analyses (Table 2) revealed that partnership
status was signiﬁcantly associated with spirituality (P =
0.03) and ethnicity, biopsy Gleason score, and cause of
deathtrendedtowardsigniﬁcance(P\0.20).Age,regionof
residence, and clinical stage at initial diagnosis were not
associated with spirituality.
Table 3 presents the distribution of spirituality and the
subscales within each type of end-of-life care received.
Ahigherproportionofmenwithhighspiritualityscores(33%)
than with low scores (13%) enrolled in hospice, although our
analysis was not powered to demonstrate statistical signiﬁ-
cance. Likewise, we saw a trend toward increased use of
palliative radiation among those with higher spirituality
(37% vs. 25%, P = 0.69). The differences in end-of-life care
received among those with low and high spirituality varied
little by the peace and faith subscales.
Table 1 Demographic and clinical characteristics of the study sample
(n = 35)
Characteristic Number of
patients (%)
Age (years ± SD)
Mean age at IMPACT enrollment 62.7 ± 9.8
Mean age at death 64.2 ± 9.7
Average length of IMPACT enrollment
at time of death (months ± SD)
18.4 ± 13.4
Ethnicity
White 6 (17.1)
African American 5 (14.3)
Hispanic 24 (68.6)
Job status
Employed 17 (48.6)
Unemployed 18 (51.4)
Number of dependents
0 13 (37.1)
C1 22 (62.9)
Partnership status
In relationship 25 (71.4)
Not in relationship 10 (28.6)
Region of residence
Northern California 11 (31.4)
Southern California 24 (68.6)
Pre-treatment PSA (1 missing)
\4 3 (8.8)
4–10 4 (11.8)
C10 27 (79.4)
Biopsy Gleason score
B6 5 (14.3)
7 11 (31.4)
C8 19 (54.3)
Clinical stage
T1 (localized) 13 (37.1)
T2 (localized) 12 (34.3)
T3 (locoregional) 5 (14.3)
T4 (metastatic) 5 (14.3)
D’amico risk stratiﬁcation
Low risk 2 (5.7)
Intermediate risk 2 (5.7)
High risk 31 (88.6)
Treatment within IMPACT
Radical prostatectomy 3 (8.6)
Radiation therapy 1 (2.9)
Radiation therapy ? androgen
deprivation therapy
4 (11.4)
Androgen deprivation monotherapy 26 (74.3)
Active surveillance 1 (2.9)
End-of-life care received
a
Hospice 10 (28.6)
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Our study has three important ﬁndings. First, in contrast
with previous analyses and our hypothesis, we noted a
trend toward higher rates of hospice utilization among
more spiritual men [9]. This suggests that highly spiritual
men redirected the focus of their care from curative goals
to palliation and quality of life. The hospice model of
patient care focuses on controlling symptoms, facilitating
emotional and spiritual well-being, ensuring patient
autonomy, and supporting caregivers [16]. Compared with
individuals dying of cancer who do not receive hospice
care, those who do have better pain control and improved
quality of life at the end of life [12, 23]. Despite this, many
people with metastatic cancer do not utilize hospice ser-
vices [14]. One reason that individuals may not enroll in
hospice is an unwillingness to forgo aggressive treatments,
even at a stage when those treatments can neither cure
disease nor improve quality of life. A recent prospective,
multisite analysis of a longitudinal cohort of individuals
with advanced cancer showed that those with higher spir-
ituality received more high-intensity, life-prolonging care
at the end of life, including mechanical ventilation or
cardiopulmonary resuscitation [9]. Such aggressive, futile
end-of-life care is antithetical to the hospice model, and
individuals who wish to aggressively treat incurable dis-
ease are less likely to enroll in hospice [10, 13, 24]. Jacobs,
et al. [8] have shown that a majority of individuals in the
general public believe God can heal a patient even after
medical providers agree the disease is no longer curable,
which may partially explain the underuse of hospice among
individuals with almost all terminal conditions [14].
That highly spiritual men within IMPACT utilized
hospice at least as often as their less-spiritual counterparts
suggests that spiritual beliefs did not prevent them from
accepting the incurability of their prostate disease. One
reason spirituality may have affected men in IMPACT
differently than it inﬂuenced subjects in the Phelps study
[9] is IMPACT’s comprehensive cancer care model. In
addition to providing prostate cancer care, IMPACT also
offers generous clinical and non-clinical services targeting
the extrinsic factors associated with disparities in treatment
outcomes among disadvantaged men. The design of the
program incorporates measures to help reduce the outcome
disparities often seen in low-income and uninsured patients
after prostate cancer treatment. These value-added services
include counseling and interpreter services, culturally
competent and literacy-sensitive educational materials in
multiple languages, transportation assistance, food security
and housing referrals, and nurse-managed care for all
IMPACT enrollees. While spirituality typically leads to
less advanced care planning and higher-intensity end-of-
life care (including less-frequent hospice use), specially
among minorities [10–11, 25], our ﬁndings suggest that
comprehensive cancer care like that delivered within
IMPACT may loosen the tether between spirituality and
aggressive end-of-life care. From a policy perspective, the
comprehensive care model may better serve both the
individual and the health care system.
Second, among men with both low and high spirituality,
the pattern of end-of-life care in our cohort was consistent
with previous reports of higher-income, insured individu-
als, although these patterns were suboptimal in both
populations. Earle, et al. [26] have identiﬁed frequent
emergency room visits, continuation of anticancer thera-
pies very near death, and a high proportion of individuals
never referred to hospice or referred in the last few days of
life as indicators of poor-quality, end-of-life care. Indi-
viduals enrolled in hospice for fewer than 7 days before
death have insufﬁcient time to beneﬁt from myriad hospice
resources, while hospice referrals made more than
180 days before dying are considered too early [13–14,
16]. Once terminally ill patients present to an emergency
room, approximately 35% are hospitalized and die during
hospital admission, while another 35% are hospitalized,
aggressively treated, and discharged [24]. Frequent emer-
gency room visits, inpatient admissions, and intensive care
unit stays not only constitute poor-quality, end-of-life
care but also contribute disproportionately to the cost of
care [27]. In our cohort, 29% of men made two or more
prostate cancer-related emergency room visits, 29%
enrolled in hospice, and none enrolled in hospice within
7 days of death. While previous studies, the majority of
Table 1 continued
Characteristic Number of
patients (%)
Zolendroic acid 16 (45.7)
Chemotherapy 22 (62.9)
Palliative radiation therapy 12 (34.3)
PSA closest to date of death (1 missing)
B4 6 (17.7)
4–10 3 (8.8)
C10 25 (73.5)
Number of prostate cancer-related emergency room visits
0 13 (37.1)
1 12 (34.3)
C2 10 (28.6)
Evidence of metastases at presentation to IMPACT
Cause of death 25 (71.4)
Prostate cancer 26 (74.3)
Other 9 (25.7)
a Types of end-of-life care were not mutually exclusive and could
therefore sum more than 100%
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individuals, reported similar utilization trends at the end of
life, our ﬁndings suggest several avenues to improve end-
of-life care [14, 28]. Addressing medical problems before
they turn emergent may obviate the need to spend one-third
of all Medicare resources at the end of life [15]. Likewise,
improving the overall rate of hospice utilization, in both
underserved individuals like those in IMPACT and in more
privileged populations, may help deliver higher-quality
end-of-life care at lower cost.
Third, the associations we noted between spirituality
and end-of-life care did not change in our subgroup anal-
yses of the peace and faith subscales of the FACIT-Sp.
Rather, the trends we noted between total FACIT-Sp scores
and use of hospice, zolendroic acid, chemotherapy, and
palliative radiation differed negligibly by the contribution
of peace or faith to spirituality. The peace subscale of the
FACIT-Sp assesses the contribution of spirituality to
meaning, peace, and purpose in life, while the faith sub-
scale measures the relationship between illness and spiri-
tual beliefs. Some previous reports have shown that the
peace subscale correlates with mental and physical health,
while faith correlates with mental health exclusively, but
the subscales are usually collinear [6, 21]. Our ﬁndings
suggest that both peace and faith affect men’s decisions at
the end of life in a similar manner. Addressing end-of-life
goals and expectations with all spiritual men may help
them navigate life’s ﬁnal chapter more knowledgeably.
Our ﬁndings are limited by several methodological
considerations. First, our small sample size risks type II
error, wherein we incorrectly failed to reject the null
hypothesis of no difference between the low- and high-
spirituality groups. We lacked power to deﬁnitively dem-
onstrate that no difference existed between men with lower
and higher spirituality. As such, our analysis is hypothesis-
generating and begs for further study. Second, the vast
majority of men in our cohort presented to IMPACT with
Table 2 Bivariate analysis of demographic and clinical characteris-
tics by spirituality scores (n = 35)
Characteristic Number of patients (%)
Low
FACIT-Sp
\27 (n = 8)
High
FACIT-Sp
C27 (n = 27)
P value
Age (years ± SD)
Mean age at IMPACT
enrollment
61 ± 96 3 ± 10 0.65
Mean age at death 63 ± 86 5 ± 10 0.60
Ethnicity
White 3 (38) 3 (11) 0.17
African American 0 (0) 5 (19)
Hispanic 5 (62) 19 (70)
Job status
Employed 2 (25) 15 (56) 0.23
Unemployed 6 (75) 12 (44)
Number of dependents
0 4 (50) 9 (33) 0.43
C1 4 (50) 18 (67)
Partnership status
In relationship 3 (38) 22 (81) 0.03
Not in relationship 5 (62) 5 (19)
Region of residence
Northern California 2 (25) 9 (33) 1.0
Southern California 6 (75) 18 (67)
Pre-treatment PSA
B4 1 (13) 2 (8) 0.61
4–10 0 (0) 4 (15)
C10 7 (87) 20 (77)
Biopsy Gleason score
B6 3 (38) 2 (7) 0.06
7 3 (38) 8 (30)
C8 2 (25) 17 (67)
Clinical stage
T1 (localized) 3 (38) 10 (37) 0.56
T2 (localized) 3 (38) 9 (33)
T3 (locoregional) 0 (0) 5 (19)
T4 (metastatic) 2 (25) 3 (11)
D’amico risk stratiﬁcation
Low risk 1 (13) 1 (4) 0.22
Intermediate risk 1 (13) 1 (4)
High risk 6 (75) 25 (93)
Treatment within IMPACT
Radical prostatectomy 1 (13) 2 (7) 0.33
Radiation therapy 0 (0) 1 (4)
Radiation therapy ? androgen
deprivation
0 (0) 4 (15)
Androgen deprivation
monotherapy
6 (75) 20 (74)
Active surveillance 1 (13) 0 (0)
PSA closest to date of death
B4 2 (25) 4 (15) 0.52
4–10 1 (13) 2 (8)
C10 5 (63) 20 (77)
Table 2 continued
Characteristic Number of patients (%)
Low
FACIT-Sp
\27 (n = 8)
High
FACIT-Sp
C27 (n = 27)
P value
Number of emergency room visits
0 2 (25) 11 (41) 0.61
1 4 (50) 8 (30)
C2 2 (25) 8 (30)
Evidence of metastases
at presentation to IMPACT
5 (63) 20 (74) 0.66
Cause of death
Prostate cancer 4 (50) 22 (81) 0.16
Other 4 (50) 5 (19)
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123metastatic disease, many after having received primary
prostate cancer treatment elsewhere. Whether the patterns
of end-of-life care we elucidated would differ if men had
been enrolled in a comprehensive cancer care program at
initial diagnosis remains an open question, and indeed a
distinct possibility.
Despite these limitations, the nature of the IMPACT
program and our data collection methods strengthen the
potential value of our conclusions. The extensive clinical
and psychosocial notes entered by IMPACT providers were
available for our perusal, so we needed not rely on analyses
based on claims or death certiﬁcates. We were able to view
all notes from medical, nursing, and ancillary providers to
understand end-of-life care in our subjects more robustly
than if we had used only administrative data.
We describe the associations between spirituality and
patterns of end-of-life care among low-income, uninsured
men with prostate cancer. End-of-life care was similar
between men with lower and higher spirituality. Patterns of
care in our underserved cohort were comparable with those
of more afﬂuent, insured individuals. These patterns
remain poorly understood and must be rationally system-
ized to ensure delivery of high-quality, cost-effective, end-
of-life care.
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